A novel mutation (deletion of Aα-Asn 80) in an abnormal fibrinogen: Fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: Peculiar clot structure and diminished stiffness of the clot

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 7, 2004, Pages 559-567

  Marchi, Rita C ^a,b   Meyer, Michael H ^c   De Bosch, Norma B ^d   Arocha Pinango C L ^b   Weisel, John W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^c UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

^d Banco Munic Sangre Distrito F   (Venezuela)

Author keywords

Coiled coil A chain; Dysfibrinogenemia; Fibrin gel rheological properties; Structure

Indexed keywords

AMINO ACID; ASPARAGINE; FIBRIN; FIBRINOGEN; FIBRINOGEN CARACAS VI; PLASMIN; THROMBIN; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BLEEDING TENDENCY; BLOOD CLOT; BLOOD RHEOLOGY; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; DYSFIBRINOGENEMIA; ELECTRON MICROSCOPY; FIBRIN POLYMERIZATION; HUMAN; HUMAN TISSUE; MALE; PERMEABILITY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; RELIABILITY; RIGIDITY; SCANNING ELECTRON MICROSCOPY; SCHOOL CHILD; SEQUENCE ANALYSIS; TURBIDITY;

EID: 5644228617     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200410000-00005     Document Type: Article

References (46)

1. Hoeprich PD, Doolittle RF. Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry 1983; 22:2049-2055.
2. Blombäck B, Yamashina I. On the N-terminal amino acids in fibrinogen and fibrin. Arkiv Kemi 1958; 12:299-319.
3. Henschen A. S-sulfo derivatives of fibrinogen and fibrin: preparations and general properties. Arki Kemi 1963; 22:1-28.
4. Blomback B. Nomenclature of fibrinogen and fibrin chains and other derivatives of fibrinogen and fibrin. Thromb Diath Haemorrh Suppl 1968; 35:161-168.
5. 2- terminal part of human fibrinogen. Thromb Res 1976; 8:639-658.
6. Blomback B, Yamashina I. On the N-terminal amino acids in fibrinogen and fibrin. Arkiv Kemi 1958; 12:299-319.
7. Caspary EA, Kekwick RA. Some physicochemical properties of human fibrinogen. Biochem J 1957; 67:41-48.
8. Hall CE, Slayter HS. The fibrinogen molecule: its size, shape and mode of polymerization. J Biophys Biochem Cytol 1959; 5:11-15.
9. Telford JN, Nagy JA, Hatcher PA, Scheraga HA. Location of peptide fragments in the fibrinogen molecule by immunoelectron microscopy. Proc Natl Acad Sci USA 1980; 77:2372-2376.
10. Rao SPS, Poojary MD, Elliott BW Jr, Melanson LA, Oriel B, Cohen C. Fibrinogen structure in projection at 18 Å resolution. Electron density by co-ordinated cryo-electron microscopy and x-ray crystallography. J Mol Biol 1991; 222:89-98.
11. Takagi T, Doolittle RF. Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments. Biochemistry 1975; 14:940-946.
12. Weisel J, Stauffacher CV, Bullitt E, Cohen C. A model for fibrinogen: domains and sequence. Science 1985; 230:1388-1391.
13. Veklich YI, Gorkun OV, Medved LV, Niewenhuizen W, Weisel JW. Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. J Biol Chem 1993; 268:13577-13585.
14. Olexa SA, Budzynski AZ. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci USA 1980; 77:1374-1378.
15. Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry 1998; 37:8637-8642.
16. Weisel JW, Phillips GN Jr, Cohen C. A model from electron microscopy for the molecular structure of fibrinogen and fibrin. Nature 1981; 289:263-267.
17. Fowler WE, Hantgan RR, Erickson HP. Structure of the fibrin protofibril. Proc Natl Acad Sci USA 1981; 78:4872-4876.
18. Weisel JW. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J 1986; 50:1079-1093.
19. Krakow W, Endres GF, Siegel BM, Scheraga HA. An electron microscopic investigation of the polymerization of bovine fibrin monomer. J Mol Biol 1972; 71:95-103.
20. Blomback B, Hessel B, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 1978; 275:501-505.
21. Hantgan RR, Hermans J. Assembly of fibrin: a light scattering study. J Biol Chem 1979; 254:11272-11281.
22. Chen R, Doolittle RF. Gamma-gamma crossfinking sites in human and bovine fibrinogen. Biochemistry 1971; 10:4487-4491.
23. Cottreli BA, Strong DD, Watt KW, Doolittle RF. Amino acid sequence studies on the alpha chain of human fibrinogen. Exact location of cross-linking acceptor sites. Biochemistry 1979; 18:5405-5410.
24. a fibrin cross-linking. J Biol Chem 1996; 271:19288-19297.
25. Shen LL, Hermans J, McDonagh J, McDonagh RP, Carr M. Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin gels. Thromb Res 1975; 6:255-265.
26. McDonagh RP Jr, McDonagh J, Duckert F. The influence of fibrin cross-linking on the kinetics of urokinase-induced clot lysis. Br J Haematol 1971; 21:323-332.
27. Francis CW, Marder VJ. Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. Blood 1988; 71:1361-1365.
28. McDonagh J. Dysfibrinogenemia and other disorders of fibrinogen structure or function. In: Robert W. Colman et al. (editors): Hemostasis and thrombosis. Basic principles and clinical practice, 4th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2001, pp. 855-892.
29. Giddings JC. The investigation of hereditary coagulation disorders. In: Thomson JD (editor): Blood coagulation and haemostasis. A practical guide. Edinburgh: Churchill Livingstone; 1980, p. 117.
30. Ingram GIC. The determination of plasma fibrinogen by the clot weight method. Biochem J 1952; 51:583-585.
31. Mosesson MW, Sherry S. The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 1966; 5:2829-2835.
32. 4. Nature (Lond) 1970; 227:680-685.
33. Bouvier CA, Gruedlinger J. Etude des phénomènes de coagulation et de fibrinolyse, par une méthode simple d'enregistrement optique. Schweiz Wzch 1963; 93:1451-1455.
34. Schägger H, Von Jagow G. Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987; 166:368-379.
35. Blombäck B, Carlsson K, Kessel B, Liljeborg A, Procyck R, Åslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989; 997:96-110.
36. Langer BG, Weisel JW, Dinauer PA, Nagaswami C, Bell WR. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem 1988; 263:15056-15063.
37. Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992; 63:111-128.
38. Janmey PA. A torsion pendulum for measurement of the viscoelasticity of biopolymers and its application to actin networks. J Biochem Biophys Methods 1991; 22:41-53.
39. Matsuda M, Sugo T. Hereditary disorders of fibrinogen. Ann NY Acad Sci 2001; 936:65-88.
40. Meyer M, Kutscher G, Hirschmann S, Hauschild F, Barthels M, Bergmann F, et al. Molecular pathology of human fibrinogen: elucidation of 10 novel mutations in dysfibrinogenemic patients [Abstract]. Thromb Haemost 2001; (suppl):P1109.
41. Maekawa H, Yamazumi K, Muramatsu S, Kaneko M, Hirata H, Takahashi N, et al. Fibrinogen Lima: a homozygous dysfibrinogen with an Aα-arginine-141 to serine substitution associated with extra N-glycosylation at Aα-asparagine-139. J Clin Invest 1992; 90:67-76.
42. Sugo T, Nakamikawa C, Takano H, Mimuro J, Yamaguchi S, Mosseson MW, et al. Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bβ Asn-160 to Ser substitution associated with extra glycosylation at Bβ Asn-158. Blood 1999; 94:3806-3813.
43. Doolittle RF, Goldbaum DM, Doolittle LR. Designation of sequences involved in the 'coiled-coil' interdomainal connections in fibrinogen: construction of an atomic scale model. J Mol Biol 1978; 120:311-325.
44. Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry 1998; 37:8637-8642.
45. Brown JH, Volkmann N, Jun G, Henschen-Edman AH, Cohen C. The crystal structure of modified bovine fibrinogen. Biochemistry 2000; 97:85-90.
46. Ryan EA, Mockros LF, Weisel JW, Lorand L. Structural origins of fibrin clot rheology. Biophys J 1999; 77:2813-2826.